/ About this event
Precision health has the potential to fundamentally change how healthcare is delivered—moving us from treating disease once it appears toward identifying risk earlier, personalizing intervention, and increasingly predicting what happens next.
Join us for a conversation about that transformation and the technologies making it possible. We’ll explore how genomics is expanding our understanding of individual health trajectories, how environmental factors are influencing fertility and reproductive outcomes, and why sex-stratified research and the health of women offers a powerful lens into the possibilities of precision care.
For founders, investors, and ecosystem leaders, the implications extend well beyond better diagnostics. Precision health has the potential to reshape where and when care happens, create entirely new categories of healthcare companies, and shift significant value toward the technologies and platforms capable of turning increasingly complex biological data into actionable intelligence.
Panelists:
Martha Lawrence - EO & Co-Founder of AccendoWave, a machine learning health care technology company that objectively measures and manages pain/discomfort. Previously, she served as President of Sequoia Healthcare Advisors, an advisory firm providing strategic innovation and investment advisory guidance.
Dr. Carmen Messerlian - Reproductive epidemiologist, researcher, and professor, with 20 years of experience researching the environmental and biological factors that affect fertility, pregnancy, and child health. She is the founder and Chief Medical Officer of Vie Science.
Kunal Karo - Founder and CEO of Eugene Labs (Eugene), and prominent advocate for making genetic testing accessible and addressing systemic biases in healthcare.
___ This event is part of #LATechWeek—a week of events hosted by VCs and startups to bring the tech ecosystem together. Learn more at www.tech-week.com.
